Skip to Main content Skip to Navigation
Journal articles

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.

Abstract : Renal toxicity constitutes a dose-limiting side effect of anticancer therapies targeting vascular endothelial growth factor (VEGF). In order to study this further, we followed up 29 patients receiving this treatment, who experienced proteinuria, hypertension, and/or renal insufficiency. Eight developed minimal change nephropathy/focal segmental glomerulopathy (MCN/FSG)-like lesions and 13 developed thrombotic microangiopathy (TMA). Patients receiving receptor tyrosine kinase inhibitors (RTKIs) mainly developed MCN/FSG-like lesions, whereas TMA complicated anti-VEGF therapy. There were no mutations in factor H, factor I, or membrane cofactor protein of the complement alternative pathway, while plasma ADAMTS13 activity persisted and anti-ADAMTS13 antibodies were undetectable in patients with TMA. Glomerular VEGF expression was undetectable in TMA and decreased in MCN/FSG. Glomeruli from patients with TMA displayed a high abundance of RelA in endothelial cells and in the podocyte nuclei, but c-mip was not detected. Conversely, MCN/FSG-like lesions exhibited a high abundance of c-mip, whereas RelA was scarcely detected. RelA binds in vivo to the c-mip promoter and prevents its transcriptional activation, whereas RelA knockdown releases c-mip activation. The RTKI sorafenib inhibited RelA activity, which then promoted c-mip expression. Thus, our results suggest that c-mip and RelA define two distinct types of renal damage associated with VEGF-targeted therapies.
Document type :
Journal articles
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00958760
Contributor : Georges Guellaen <>
Submitted on : Friday, March 28, 2014 - 7:00:08 AM
Last modification on : Wednesday, August 19, 2020 - 11:17:02 AM
Long-term archiving on: : Saturday, June 28, 2014 - 10:37:43 AM

File

VEGF_paper.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Hassan Izzedine, Melanie Mangier, Virginie Ory, Shao-Yu Zhang, Kelhia Sendeyo, et al.. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.. Kidney International, Nature Publishing Group, 2014, 85 (2), pp.457-70. ⟨10.1038/ki.2013.344⟩. ⟨inserm-00958760⟩

Share

Metrics

Record views

746

Files downloads

623